Alexion Pharmaceuticals Inc (ALXN.O)

ALXN.O on Nasdaq

117.21USD
1 Aug 2013
Price Change (% chg)

$1.02 (+0.88%)
Prev Close
$116.19
Open
$117.55
Day's High
$118.40
Day's Low
$116.44
Volume
1,233,893
Avg. Vol
1,690,628
52-wk High
$125.65
52-wk Low
$81.82

ALXN.O

Chart for ALXN.O

About

Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its marketed product Soliris (eculizumab) is the first and only therapeutic approved for patients with... (more)

Overall

Beta: 0.57
Market Cap (Mil.): $22,721.88
Shares Outstanding (Mil.): 195.56
Dividend: --
Yield (%): --

Financials

  ALXN.O Industry Sector
P/E (TTM): 66.21 37.93 37.76
EPS (TTM): 1.75 -- --
ROI: 15.29 19.48 18.76
ROE: 17.73 20.17 19.59
Search Stocks

Alexion shares rise after report of approach by Roche

- Shares of Alexion Pharmaceuticals Inc rose more than 7 percent on Tuesday following a report that Swiss drugmaker Roche Holding AG made an informal approach to the biotech company last week about a takeover.

30 Jul 2013

Alexion shares rise after report of approach by Roche

July 30 - Shares of Alexion Pharmaceuticals Inc rose more than 7 percent on Tuesday following a report that Swiss drugmaker Roche Holding AG made an informal approach to the biotech company last week about a takeover.

30 Jul 2013

UPDATE 1-Alexion valuation could choke any Roche bid

* Roche seeking financing for potential Alexion bid- sources

15 Jul 2013

Alexion valuation could choke any Roche bid

* Roche seeking financing for potential Alexion bid- sources

14 Jul 2013

Roche seeks financing for potential Alexion bid: sources

NEW YORK/LOS ANGELES - Swiss drugmaker Roche Holding AG is seeking financing for a potential bid for Alexion Pharmaceuticals Inc , a transaction that if successful would be the largest healthcare deal of the year, two people familiar with the matter said on Friday.

12 Jul 2013

UPDATE 3-Roche seeks financing for potential Alexion bid -sources

* Alexion shares close almost 13 percent higher (Adds analyst comments)

12 Jul 2013

Roche seeks financing for potential Alexion takeover -sources

NEW YORK, July 12 - Swiss drugmaker Roche Holding AG is seeking financing for a potential takeover of Alexion Pharmaceuticals Inc, two people familiar with the matter said on Friday.

12 Jul 2013

BRIEF-Alexion Pharmaceuticals shares up 3.1 percent in premarket trade following results

NEW YORK, April 25 - Alexion Pharmaceuticals Inc : * Shares up 3.1 percent in premarket trade following results

25 Apr 2013

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$472.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks